Reality-monitoring & Stress (REALIST)

March 6, 2024 updated by: Hôpital le Vinatier

Study of Reality-monitoring Process and Influence of Stress Using an Electrophysiological Approach

Reality-monitoring is a crucial cognitive process in daily life to remember the source of an information. Deficits of reality-monitoring have been shown into the continuum of schizophrenia, suggesting a preexisting alteration in population at-risk for psychosis that will be exacerbated during psychotic transition. It is admitted that stress plays a crucial role in the psychotic transition and can alter cognitive performances. However, less is known about the effects of stress on reality-monitoring, even though this process appears to be central in psychotic disorders.

The aim of this project is to investigate the effect of stress on reality-monitoring, both on behavioral and neurophysiological aspects

Study Overview

Detailed Description

Forty healthy subjects will be included in the study. Participants will be subject to a standardized stress protocol, half of them receiving an active stress and the other half receiving a placebo. All participants will also complete a reality-monitoring task, electrophysiological (EEG) recordings as well as socio-demographic and psychometric evaluations

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Right-handed Men and Women aged between 18 and 30
  • Having given their written informed consent
  • For women: oral contraceptive use
  • French speakers and readers

Exclusion Criteria:

  • Do not consent to be included in the study
  • Smokers
  • Night workers
  • Having visual or hearing impairments that could prevent the successful completion of tasks involving reading or listening to sounds
  • Taking drug treatment (except oral contraceptive)
  • Having a somatic pathology in particular neurological, endocrinal or blood circulation diseases (e.g., Raynaud's disease)
  • Having personal or first-degree relatives' history of diagnosed psychiatric disorders (according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - DSM5)
  • Having psychotic prodomes measured by a score above 6 in the "prodomal questionnaire' - PQ-16 (Ising et al., 2012)
  • Having developed musical abilities (that is, regularly practicing a musical instrument)
  • Being pregnant or nursing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: active stress group
20 healthy subjects will be subject to the active condition of a standardized stress protocol
The MAST is a standardized stress protocol combining a 5 min preparation phase and 10 min acute stress phase. The last phase is composed by an alternation of physical and psychosocial stressors. In the active condition, participants have to switch between immersion of the hand into cold water and complex mental arithmetic operations.
Placebo Comparator: placebo stress group
20 healthy subjects will be subject to the placebo condition of a standardized stress protocol.
The MAST is a standardized stress protocol combining a 5 min preparation phase and 10 min acute stress phase. The last phase is composed by an alternation of physical and psychosocial stressors. In the placebo condition, participants have to switch between immersion of the hand into tempered water and simple mental arithmetic counts.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reality-monitoring performances
Time Frame: within 1 hour after the stress procedure
scores obtained at the reality-monitoring task (accuracy, range 0-100%)
within 1 hour after the stress procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
electroencephalogram (EEG) activity
Time Frame: 1time within 1 hour after the stress procedure
EEG activity recorded at rest (spectral power) and during reality-monitoring task
1time within 1 hour after the stress procedure
Working memory
Time Frame: 1 time within 1 hour after the stress procedure
scores at the n-back task (expressed as % of good responses)
1 time within 1 hour after the stress procedure
Basic auditory performances
Time Frame: 1 time within 1 hour after the stress procedure
scores at the Tone Matching Task (expressed as % of good responses)
1 time within 1 hour after the stress procedure
Salivary cortisol
Time Frame: throughout and within 1 hour after the stress procedure
Salivary cortisol (in µg/L)
throughout and within 1 hour after the stress procedure
Blood pressure
Time Frame: throughout and within 1 hour after the stress procedure
blood pressure (both systolic and diastolic, in mmHg)
throughout and within 1 hour after the stress procedure
Heart rate
Time Frame: throughout and within 1 hour after the stress procedure
Heart rate (in beats per minute)
throughout and within 1 hour after the stress procedure
expression rate of genes involved in the regulation of the glucocorticoid receptor signaling pathway
Time Frame: 1 time before and 1 time 1 hour after the stress procedure
The expression rate of genes of the glucocorticoid receptor signaling pathway (NR3C1, FKBP4, HSP90, HSP70, FKBP5, BAG1, PTGES3)
1 time before and 1 time 1 hour after the stress procedure
Subjective stress
Time Frame: 1 time before and 1 time 1 hour after the stress procedure
Subjective stress assessed with the STAI-YA (scores between 20 and 80)
1 time before and 1 time 1 hour after the stress procedure
Psychometric characteristics that may influence stress response (1)
Time Frame: Basline, before the stress procedure
Scores at the 16-item Prodromal Questionnaire (PQ-16), ranging between 0 and 16 (higher scores indicate higher psychotic risks).
Basline, before the stress procedure
Psychometric characteristics that may influence stress response (2)
Time Frame: Basline, before the stress procedure
Scores at the Childhood Trauma Questionnaire (CTQ), between 28 and 140 (higher scores indicate higher trauma exposure)
Basline, before the stress procedure
Psychometric characteristics that may influence stress response (3)
Time Frame: Basline, before the stress procedure
State Trait Anxiety Inventory (form B) scores between 40 and 160 20 and 80 (STAI-YB) between 20 and 80 (higher scores indicate higher state anxiety)
Basline, before the stress procedure
Psychometric characteristics that may influence stress response (4)
Time Frame: Basline, before the stress procedure
Scores at the Schizotypal Personality Questionnaire (SPQ), between 0 and 74 (higher scores indicate higher schizotypal traits)
Basline, before the stress procedure
Psychometric characteristics that may influence stress response (5)
Time Frame: Basline, before the stress procedure
Scores at the Launay-Slade Hallucinations Scale (LSHS), between 0 and 64 (higher scores indicate a greater likelihood of experiencing hallucinations)
Basline, before the stress procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mondino Marine, PhD, hospital le Vinatier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 30, 2024

Primary Completion (Estimated)

January 16, 2025

Study Completion (Estimated)

November 16, 2025

Study Registration Dates

First Submitted

October 13, 2022

First Submitted That Met QC Criteria

October 24, 2022

First Posted (Actual)

October 27, 2022

Study Record Updates

Last Update Posted (Actual)

March 7, 2024

Last Update Submitted That Met QC Criteria

March 6, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-A01390-43

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Participants

Clinical Trials on Acute Maastricht Stress Test (MAST), active condition.

3
Subscribe